Focus Partners Wealth’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-12,989
Closed -$17K – 2860
2026
Q1
$17K Sell
12,989
-2,814
-18% -$5.29K ﹤0.01% 2621
2025
Q4
$37.8K Buy
15,803
+3,281
+26% +$8.97K ﹤0.01% 2614
2025
Q3
$36.3K Sell
12,522
-9,993
-44% -$34.2K ﹤0.01% 2169
2025
Q2
$84.9K Buy
22,515
+12,317
+121% +$48.5K ﹤0.01% 1953
2025
Q1
$46.2K Buy
+10,198
New +$54K ﹤0.01% 1847

Other funds holding HCAT

Focus Partners Wealth's HCAT Position: Q2 2026 in Review

Focus Partners Wealth sold out of Health Catalyst (HCAT) in Q2 2026, closing a stake of 12,989 shares — an estimated $17K sold.

Focus Partners Wealth first reported a position in HCAT in Q1 2025 and held it in 5 quarters. The position peaked at $84.9K in Q2 2025. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Focus Partners Wealth reported no remaining Health Catalyst position as of Q2 2026 after selling out during the quarter.
  • Focus Partners Wealth sold 12,989 Health Catalyst shares in Q2 2026, an estimated $17K.
  • Focus Partners Wealth first reported a position in Health Catalyst in Q1 2025 and held it in 5 quarters.
  • Focus Partners Wealth's Health Catalyst position peaked at $84.9K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.